<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02161133</url>
  </required_header>
  <id_info>
    <org_study_id>SPLD-009-13S</org_study_id>
    <nct_id>NCT02161133</nct_id>
  </id_info>
  <brief_title>Cognitive Rehabilitation for Gulf War Illness</brief_title>
  <official_title>Cognitive Rehabilitation for Gulf War Illness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are almost 700,000 Gulf War Veterans (GWV) with 25-30% suffering from a devastating
      multi-symptom illness coined Gulf War Illness (GWI). GWV with GWI report significant activity
      limitations and chronic cognitive problems consistent with problem-solving deficits.
      Problem-solving is considered the most complex of cognitive abilities and is what enables us
      to conduct complicated behaviors such as setting goals, sequencing and multi-tasking. As a
      result studies have found that problem-solving deficits are prospectively related to a
      greater risk of disability. Despite published reports documenting these problems there are no
      treatments that target the problem-solving deficits of GWI. This proposal seeks to determine
      whether Problem-Solving Therapy, a patient centered cognitive rehabilitation therapy, can
      reduce disability by compensating for problem-solving deficits.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gulf War Illness (GWI) is a complex multi-dimensional illness which causes as much disability
      as other major medical diseases. Previous clinical trials (i.e. cognitive behavioral therapy
      and graded exercise) for GWI have sought to improve disability by increasing activity
      regardless of symptom presentation. These previous trials for GWI have shown limited efficacy
      and poor adherence. An innovative treatment approach is to target a specific component of
      GWI, namely problem-solving ability, known to be associated with disability.

      Impairment in problem-solving ability affects Gulf War Veterans (GWV) with GWI and is
      prospectively related to greater risk of disability. This impairment is also related to
      poorer adherence to medical regimes, making it difficult for GWV to manage other aspects of
      GWI. Problem-solving is considered one of the most complex of cognitive abilities and is
      related to complicated behaviors such as setting goals, sequencing and multi-tasking. Despite
      published reports documenting these deficits there are no treatments that target the
      problem-solving deficits of GWI in order to reduce disability.

      The investigators propose a targeted treatment, Problem-Solving Therapy, to compensate for
      the problem-solving deficits of GWI and thereby reducing disability. Problem-Solving Therapy,
      a top down approach, teaches patients skills to overcome problems like cognitive dysfunction
      or physical symptoms that impact problem-solving. Compensating for problem-solving deficits
      would reduce disability and provide information on the effect of treating one component of
      GWI on other symptoms of GWI. This is the first trial of cognitive rehabilitation therapy for
      GWI.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Actual">September 1, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disability - WHO-DAS 2 Change</measure>
    <time_frame>Baseline and 12 weeks</time_frame>
    <description>World Health Organization Disability Assessment Schedule.
The WHO-DAS 2.0 measures disability due to physical and mental health conditions. The WHO-DAS 2.0 is a 36 item measure that focuses upon six life tasks:
Understanding and communicating
Self-care
Mobility (getting around)
Interpersonal relationships (getting along with others)
Work and household roles (life activities)
Community and civic roles (participation)
These six life tasks reflect two underlying constructs: Activity limitations and Participation deficits. Scores range from 0-100 with higher scores = more disability.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Problem-Solving Inventory Change</measure>
    <time_frame>Baseline and 12 weeks</time_frame>
    <description>Self-report problem-solving ability. Scores range from 32-192 with lower scores equally better problem-solving ability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Problem-Solving Ability Change</measure>
    <time_frame>Baseline and 12 weeks</time_frame>
    <description>Neuropsychological Battery includes: Halstead Category Test, Russell Revised Version, The Conner's Continuous Performance Test-3 (CPT-3), Stroop Color and Word Test, Trails Making Test A and B (TMT), Rey-15 problem-solving ability will be created by standardizing (i.e., converting to z-scores) the following neuropsychological tests based on administrative norms and averaging them. The investigators will also explore the impact of Problem-Solving Therapy on each test individually.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue Change</measure>
    <time_frame>Baseline and 12 weeks</time_frame>
    <description>The Fatigue Severity Scale (FSS). Scale from 9 to 63 with higher scores = worse fatigue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Disability Change</measure>
    <time_frame>Baseline and 12 weeks</time_frame>
    <description>Pain Disability Index (PDI). Scale ranges from 0-70 with higher scores meaning worse disability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multidimensional Pain Inventory - Pain Severity Subscale Change</measure>
    <time_frame>baseline and 12 weeks</time_frame>
    <description>three items assessing pain severity. scores range 0-18 with higher scores=worse severity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">268</enrollment>
  <condition>Gulf War Illness</condition>
  <arm_group>
    <arm_group_label>Problem-Solving Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Problem-Solving Therapy is a treatment approach that teaches patients strategies to address real-life problems.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health Education</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Health education provides didactic information about Gulf War Illness</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Problem-Solving Therapy</intervention_name>
    <description>Problem-Solving Therapy is a treatment approach that teaches patients strategies to address real-life problems.</description>
    <arm_group_label>Problem-Solving Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Health Education</intervention_name>
    <description>Health Education provides didactic information about Gulf War Illness</description>
    <arm_group_label>Health Education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Inclusion:

          -  deployed to first Gulf War and meets Kansas definition for GWI (see definition in
             measures section);

          -  scores at least a half a standard deviation worse than the mean on the World Health
             Organization Disability Schedule (WHO-DAS II).

        Exclusion Criteria:

        Exclusion:

          -  current suicidal/homicide intent or plan assessed by The Columbia Suicide Severity
             Rating Scale, schizophrenia or current psychotic symptoms

          -  self-reported diagnosis of a degenerative brain disorder or serious psychiatric or
             medical illness which may limit generalizability of the findings, limit safety or
             account for the symptoms of GWI.

        Exclusionary medical illnesses include: Class 3 and 4 heart failure, cancer diagnosed
        within the past year and/or undergoing active treatment (chemotherapy or radiation
        therapy), chronic renal insufficiency, hospitalization due to myocardial infarct, stroke in
        the past year, a neurodegenerative disorder, or another medical or psychiatric disorder
        that may limit generalizability, limit participants safety or account for the symptoms of
        GWI at the discretion of the PI.

          -  a disability that would preclude telephone use.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa M McAndrew, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA</name>
      <address>
        <city>Bedford</city>
        <state>Massachusetts</state>
        <zip>01730</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ</name>
      <address>
        <city>East Orange</city>
        <state>New Jersey</state>
        <zip>07018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Canandaigua VA Medical Center, Canandaigua, NY</name>
      <address>
        <city>Canandaigua</city>
        <state>New York</state>
        <zip>14424</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>June 9, 2014</study_first_submitted>
  <study_first_submitted_qc>June 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2014</study_first_posted>
  <results_first_submitted>March 2, 2020</results_first_submitted>
  <results_first_submitted_qc>May 21, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 4, 2020</results_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Veterans</keyword>
  <keyword>neuropsychology</keyword>
  <keyword>fatigue</keyword>
  <keyword>Chronic Multisymptom Illness</keyword>
  <keyword>Gulf War Illness</keyword>
  <keyword>behavioral treatment</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 2, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/33/NCT02161133/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Problem-Solving Therapy</title>
          <description>Problem-Solving Therapy is a treatment approach that teaches patients strategies to address real-life problems.
Problem-Solving Therapy: Problem-Solving Therapy is a treatment approach that teaches patients strategies to address real-life problems.</description>
        </group>
        <group group_id="P2">
          <title>Health Education</title>
          <description>Health education provides didactic information about Gulf War Illness
Health Education: Health Education provides didactic information about Gulf War Illness</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="135"/>
                <participants group_id="P2" count="133"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="116"/>
                <participants group_id="P2" count="122"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Problem-Solving Therapy</title>
          <description>Problem-Solving Therapy is a treatment approach that teaches patients strategies to address real-life problems.
Problem-Solving Therapy: Problem-Solving Therapy is a treatment approach that teaches patients strategies to address real-life problems.</description>
        </group>
        <group group_id="B2">
          <title>Health Education</title>
          <description>Health education provides didactic information about Gulf War Illness
Health Education: Health Education provides didactic information about Gulf War Illness</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="135"/>
            <count group_id="B2" value="133"/>
            <count group_id="B3" value="268"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.1" spread="7.6"/>
                    <measurement group_id="B2" value="52.8" spread="7.0"/>
                    <measurement group_id="B3" value="52.9" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="120"/>
                    <measurement group_id="B2" value="117"/>
                    <measurement group_id="B3" value="237"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="118"/>
                    <measurement group_id="B2" value="115"/>
                    <measurement group_id="B3" value="233"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                    <measurement group_id="B2" value="88"/>
                    <measurement group_id="B3" value="179"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="135"/>
                    <measurement group_id="B2" value="133"/>
                    <measurement group_id="B3" value="268"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>World Health Organization DIsability Assessment Schedule 2.0</title>
          <description>World Health Organization Disability Assessment Schedule.
The WHO-DAS 2.0 measures disability due to physical and mental health conditions. It reflects two underlying constructs: Activity limitations and Participation deficits. Scores range from 0-100 with higher scores = more disability.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46" spread="18.1"/>
                    <measurement group_id="B2" value="44.8" spread="19.1"/>
                    <measurement group_id="B3" value="45.4" spread="18.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Disability - WHO-DAS 2 Change</title>
        <description>World Health Organization Disability Assessment Schedule.
The WHO-DAS 2.0 measures disability due to physical and mental health conditions. The WHO-DAS 2.0 is a 36 item measure that focuses upon six life tasks:
Understanding and communicating
Self-care
Mobility (getting around)
Interpersonal relationships (getting along with others)
Work and household roles (life activities)
Community and civic roles (participation)
These six life tasks reflect two underlying constructs: Activity limitations and Participation deficits. Scores range from 0-100 with higher scores = more disability.</description>
        <time_frame>Baseline and 12 weeks</time_frame>
        <population>overall number of participants analyzed represent number who completed the who-das at 12 week follow up</population>
        <group_list>
          <group group_id="O1">
            <title>Problem-Solving Therapy</title>
            <description>Problem-Solving Therapy is a treatment approach that teaches patients strategies to address real-life problems.
Problem-Solving Therapy: Problem-Solving Therapy is a treatment approach that teaches patients strategies to address real-life problems.</description>
          </group>
          <group group_id="O2">
            <title>Health Education</title>
            <description>Health education provides didactic information about Gulf War Illness
Health Education: Health Education provides didactic information about Gulf War Illness</description>
          </group>
        </group_list>
        <measure>
          <title>Disability - WHO-DAS 2 Change</title>
          <description>World Health Organization Disability Assessment Schedule.
The WHO-DAS 2.0 measures disability due to physical and mental health conditions. The WHO-DAS 2.0 is a 36 item measure that focuses upon six life tasks:
Understanding and communicating
Self-care
Mobility (getting around)
Interpersonal relationships (getting along with others)
Work and household roles (life activities)
Community and civic roles (participation)
These six life tasks reflect two underlying constructs: Activity limitations and Participation deficits. Scores range from 0-100 with higher scores = more disability.</description>
          <population>overall number of participants analyzed represent number who completed the who-das at 12 week follow up</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="110"/>
                <count group_id="O2" value="117"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.81" spread="1.16"/>
                    <measurement group_id="O2" value="-2.21" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Problem-Solving Inventory Change</title>
        <description>Self-report problem-solving ability. Scores range from 32-192 with lower scores equally better problem-solving ability.</description>
        <time_frame>Baseline and 12 weeks</time_frame>
        <population>The number of participants represents the number of participants who completed the psi at 12 week follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>Problem-Solving Therapy</title>
            <description>Problem-Solving Therapy is a treatment approach that teaches patients strategies to address real-life problems.
Problem-Solving Therapy: Problem-Solving Therapy is a treatment approach that teaches patients strategies to address real-life problems.</description>
          </group>
          <group group_id="O2">
            <title>Health Education</title>
            <description>Health education provides didactic information about Gulf War Illness
Health Education: Health Education provides didactic information about Gulf War Illness</description>
          </group>
        </group_list>
        <measure>
          <title>Problem-Solving Inventory Change</title>
          <description>Self-report problem-solving ability. Scores range from 32-192 with lower scores equally better problem-solving ability.</description>
          <population>The number of participants represents the number of participants who completed the psi at 12 week follow-up</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="113"/>
                <count group_id="O2" value="120"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.43" spread=".42"/>
                    <measurement group_id="O2" value="-1.32" spread=".41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Problem-Solving Ability Change</title>
        <description>Neuropsychological Battery includes: Halstead Category Test, Russell Revised Version, The Conner's Continuous Performance Test-3 (CPT-3), Stroop Color and Word Test, Trails Making Test A and B (TMT), Rey-15 problem-solving ability will be created by standardizing (i.e., converting to z-scores) the following neuropsychological tests based on administrative norms and averaging them. The investigators will also explore the impact of Problem-Solving Therapy on each test individually.</description>
        <time_frame>Baseline and 12 weeks</time_frame>
        <posting_date>08/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fatigue Change</title>
        <description>The Fatigue Severity Scale (FSS). Scale from 9 to 63 with higher scores = worse fatigue</description>
        <time_frame>Baseline and 12 weeks</time_frame>
        <posting_date>08/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Disability Change</title>
        <description>Pain Disability Index (PDI). Scale ranges from 0-70 with higher scores meaning worse disability.</description>
        <time_frame>Baseline and 12 weeks</time_frame>
        <posting_date>08/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Multidimensional Pain Inventory - Pain Severity Subscale Change</title>
        <description>three items assessing pain severity. scores range 0-18 with higher scores=worse severity</description>
        <time_frame>baseline and 12 weeks</time_frame>
        <posting_date>08/2020</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>9 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Problem-Solving Therapy</title>
          <description>Problem-Solving Therapy is a treatment approach that teaches patients strategies to address real-life problems.
Problem-Solving Therapy: Problem-Solving Therapy is a treatment approach that teaches patients strategies to address real-life problems.</description>
        </group>
        <group group_id="E2">
          <title>Health Education</title>
          <description>Health education provides didactic information about Gulf War Illness
Health Education: Health Education provides didactic information about Gulf War Illness</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="135"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ER Visit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract surgery; overnight stay. Increased dizziness.</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ER visit</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Admitted to hospital for severe abdominal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>ER Visit</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="135"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Scheduled plastic surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Hospitalized for abdominal pain; Dx with hernia and discharged 3 days after</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Admitted to hospital for passing out on motorcycle.</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Hip replacement and diagnosed with heart disease approx. 1 month after hip replacement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>ER Visit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Admitted to hospital for numbness in arm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>ER Visit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>increasing emotionally labile, tearful, disorganized thinking</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>increased nightmares</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Overwhelmed from reflecting about GWI Sx. Felt better after journaling.</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Emotional difficulty during QI. Nighmares after Baseline Visit.</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Increased depression and Suicidal Ideation. Has chronic SI.</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Increase in intensity of suicidal ideation without intent. Has a history of SI.</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Increased headaches; previous unreported passive SI when experience headache episode.</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>ER Visit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Increased suicidal ideation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Admitted to hospital for pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>ER Visit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>ER Visit</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Kidney removed; no chemo or radiation at this time</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Unplanned surgery for intestinal blockage.</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Hospitalized for same day posterior cervical laminectomy surgery.</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Hospital same day surgery for cyst removal from lower back.</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Hysterectomy surgery and overnight stay at hospital. ER on different day for abnormal amount of blee</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Dx with Kidney cancer; operation to remove cancer - hospitalized 2 days.</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Right nephrectomy due to mass found in kidney. Hospitalized for 2 days and discharged.</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="135"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Chest spasms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Recurrence of IBS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>ER Visit</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Herniated disk</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Extreme pain and heat in body</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Heartburn, vertigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Excessive daytime sleepiness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Cramping L hand and R foot</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Foot issue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Torn bicep muscle playing ball</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Thrown out back from building shelves and drawers.</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Hand numbness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Left shoulder pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Pain up R arm and hand</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Trouble with memory - signing name</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Increased pain and sciatica due to increased exercise on treadmill/stationary bike.</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Increasing arthritis pain in foot since car accident 3 months ago.</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>distressing memories</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Increased frequency of nightmares as a result of increasing social activities</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Increased frequency of nightmares to 1/week from 3-4 times/year.</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Passive SI without intent or plan.</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>PTSD symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Sinusitis/bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rash on face, affecting eyes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
              <event>
                <sub_title>Rash on left ear</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Mononucleosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lisa McAndrew</name_or_title>
      <organization>Veterans Affairs New Jersey Healthcare System</organization>
      <phone>862-400-3317</phone>
      <email>lisa.mcandrew@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

